Journal
SOUTHERN MEDICAL JOURNAL
Volume 102, Issue 1, Pages 60-66Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/SMJ.0b013e318188898e
Keywords
diabetes; glucose; glycemic control; hyperglycemia; postprandial
Categories
Funding
- Novo Nordisk, Inc
Ask authors/readers for more resources
Increasing evidence supports the importance of postprandial glucose (PPG) in glycemic control with regard to the development of complications in patients with diabetes. PPG plays a critical role in determining overall glycemic control, particularly in patients who are close to their glycemic goals. Data also indicate that postprandial hyperglycemia may have a greater effect on the development of cardiovascular complications compared with elevated fasting plasma glucose. Several antidiabetic agents that specifically target PPG are currently available, including glinides, glucagon-like peptide-I mimetics, dipeptidyl peptidase-4 inhibitors, and rapid-acting insulin analogs. A more intensive approach to managing PPG may improve the care of patients with diabetes and, ultimately, the outcome of these patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available